Leukocyte Disorders: Clinical Trials

1,042 trials for Leukocyte Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

552 completed, 150 unknown, 106 recruiting, 89 terminated. 277 Phase 2, 146 Phase 3, 141 Not applicable, 139 Phase 1, 84 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2277Completed 158, Terminated 36, Unknown 25, Recruiting 21, Active not recruiting 15, Withdrawn 10, Not yet recruiting 7, Enrolling by invitation 4, Suspended 1
Phase 3146Completed 91, Terminated 19, Unknown 15, Active not recruiting 9, Recruiting 5, Withdrawn 5, Not yet recruiting 2
Not applicable141Completed 61, Unknown 22, Not yet recruiting 15, Recruiting 14, Terminated 13, Withdrawn 10, Active not recruiting 5, Enrolling by invitation 1
Phase 1139Completed 84, Terminated 12, Unknown 12, Recruiting 9, Withdrawn 9, Active not recruiting 6, Enrolling by invitation 4, Not yet recruiting 3
Phase 484Completed 39, Unknown 22, Terminated 6, Recruiting 5, Active not recruiting 4, Not yet recruiting 4, Enrolling by invitation 2, Withdrawn 2
Early Phase 113Completed 4, Active not recruiting 2, Terminated 2, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1

Follow Leukocyte Disorders: new trials by email Literature Review of Leukocyte Disorders trials Research Report on Leukocyte Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lentiviral Gene Therapy for CGD
Infusion of lentiviral TYF-CGD-modified autologous stem cells - Chronic Granulomatous Disease
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-07-012026-08-26
Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy
ceftazidime, ciprofloxacin, Standard-of-Care Antibiotic Strategy - Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM)
Phase 2Not yet recruitingZealand University Hospital1502027-03-012026-09-25
G-CSF In Neonatal Sepsis With Neutropenia
Granulocyte-colony stimulating factor (G-CSF), Standard Sepsis Management - Neonatal Sepsis, Neutropenia
Not applicableNot yet recruitingUniversity of Health Sciences Lahore522027-02-152026-10-22
A Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Tolerability of Filgrastim Biosimilar and Neupogen Reference Product in Healthy Volunteers
Biofilgragen, Neupogen (filgrastim) - Neutropenia (Low White Blood Cell Count)
Phase 1Not yet recruitingBioGeneric Pharma502026-12-152026-10-20
Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
Acupuncture - Febrile Neutropenia, Sarcoma
Not applicableNot yet recruitingShaare Zedek Medical Center602026-12-012026-04-29
Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia
Remote temperature monitoring device, Home temperature monitoring by a nurse - Oncopediatrics, Febrile Neutropenia
Not applicableNot yet recruitingCentre Hospitalier Universitaire de la Réunion302026-12-012026-10-23
Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department
Haloperidol - Cannabinoid Hyperemesis Syndrome
Early Phase 1Not yet recruitingUniversity of Illinois at Chicago1002026-11-012026-09-01
Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma
Depemokimab - Allergic Bronchopulmonary Aspergillosis, ABPA
Not applicableNot yet recruitingQianfoshan Hospital102026-11-012026-09-24
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
Esophageal string test - Dysphagia, Eosinophilic Esophagitis
Not applicableRecruitingNational Institute of Allergy and Infectious Diseases (NIAID)702026-10-282026-10-23
Effects of Resistance Training on Recovery During Hematopoietic Stem Cell Transplantation
8-week Elastic Band Resistance Training Program - Hematologic Malignancies, Hematopoietic Stem Cell Transplantation
Not applicableNot yet recruitingTaipei Veterans General Hospital, Taiwan862026-10-122026-10-14
REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)
Biologic Therapy - Asthma; Eosinophilic
Not applicableNot yet recruitingWestern University, Canada2002026-10-012026-07-31
Correlation Between ANC and Bone Pain in Breast Cancer Patients Receiving Long-Acting G-CSF
Breast Cancer, Chemotherapy-Induced Neutropenia
Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University1322026-09-302026-09-08
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
Upadacitinib 30mg Dose, Upadacitinib Matching Placebo - EoE, Eosinophilic Esophagitis
Phase 2RecruitingUniversity of North Carolina, Chapel Hill522026-09-302026-10-06
Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriaceae
Hemato-oncologic Patients, Colonization
Not yet recruitingFundación Pública Andaluza para la gestión de la Investigación en Sevilla5352026-09-042026-09-03
Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)
Levofloxacin, Usual Care - Myeldysplastic Syndrome (MDS), MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)
Phase 2Not yet recruitingUniversity of Manitoba752026-09-012026-06-29
Open-label Gene Therapy Study in p47-CGD
SGX-001 - Chronic Granulomatous Disease (CGD)
Phase 1 / Phase 2RecruitingSomagenetix AG52026-08-182026-09-17
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
Dibotatug (DR-01) - Bone Marrow Failure Syndromes, Aplastic Anemias
Phase 1 / Phase 2Not yet recruitingDren Bio602026-08-012026-07-24
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Benralizumab - Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Phase 3RecruitingAstraZeneca2302026-07-242026-09-22
Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions
EndoFlip - Dysphagia, Esophageal Stricture
Not applicableRecruitingJohns Hopkins University252026-07-242026-08-24
NAI for Sepsis With Persistent Lymphopenia
Nogapendekin alfa inbakicept (NAI), Standard of Care (SOC) - Sepsis, Septic Shock
Phase 2Not yet recruitingImmunityBio, Inc.502026-07-062026-05-11

Showing 20 of 1042. Sign in to see all of them.

Narrower conditions

Neutropenia (291)  ·  Eosinophilic Esophagitis (234)  ·  Febrile Neutropenia (143)  ·  Pulmonary Eosinophilia (103)  ·  Granulomatous Disease, Chronic (78)  ·  Asthma (69)  ·  Breast Neoplasms (58)  ·  Neoplasms (57)  ·  Eosinophilia (51)  ·  Infections (50)  ·  Fever (49)  ·  Lymphopenia (42)  ·  Wiskott-Aldrich Syndrome (41)  ·  Hypereosinophilic Syndrome (40)  ·  Thrombocytopenia (40)

Broader conditions

Hemic and Lymphatic Diseases (1042)  ·  Hematologic Diseases (1010)  ·  Immune System Diseases (583)  ·  Cytopenia (513)  ·  Leukopenia (494)  ·  Agranulocytosis (408)  ·  Eosinophilia (355)  ·  Hypersensitivity, Immediate (302)  ·  Hypersensitivity (294)  ·  Digestive System Diseases (274)  ·  Pathological Conditions, Signs and Symptoms (272)  ·  Gastrointestinal Diseases (254)  ·  Gastroenteritis (240)  ·  Esophageal Diseases (223)

Interventions

Filgrastim (40)  ·  pegfilgrastim (39)  ·  mepolizumab (32)  ·  Cyclophosphamide (27)  ·  benralizumab (19)  ·  dupilumab (19)  ·  Fluticasone (17)  ·  Busulfan (15)  ·  Budesonide (12)  ·  Ciprofloxacin (12)  ·  Cyclosporine (12)  ·  Cefepime (11)  ·  Granulocyte Colony-Stimulating Factor (11)  ·  Alemtuzumab (10)  ·  Meropenem (10)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (67)  ·  Mayo Clinic (26)  ·  AstraZeneca (23)  ·  GlaxoSmithKline (18)  ·  National Heart, Lung, and Blood Institute (NHLBI) (17)  ·  Amgen (16)  ·  Children's Hospital Medical Center, Cincinnati (14)  ·  Pfizer (12)  ·  M.D. Anderson Cancer Center (11)  ·  Novartis Pharmaceuticals (11)  ·  University of Colorado, Denver (11)  ·  Assistance Publique - Hôpitaux de Paris (10)  ·  National Cancer Institute (NCI) (10)  ·  Sandoz (10)  ·  University of North Carolina, Chapel Hill (9)

Countries

United States (478)  ·  France (93)  ·  Canada (75)  ·  Germany (71)  ·  China (70)  ·  Italy (68)  ·  United Kingdom (67)  ·  Spain (53)  ·  Belgium (43)  ·  Netherlands (40)  ·  Australia (39)  ·  South Korea (39)  ·  Poland (38)  ·  Switzerland (38)  ·  Israel (33)

Top investigators

Elizabeth M Kang, M.D. (9)  ·  Evan S Dellon, MD, MPH (8)  ·  Amy D Klion, M.D. (6)  ·  Craig Paterson, MD (5)  ·  Joshua B Wechsler, MD (5)  ·  Marc E Rothenberg, MD, PhD (5)  ·  Marc E. Rothenberg, M.D., Ph.D. (5)  ·  Danielle M Townsley, M.D. (4)

Results publications

PMID 39903535, PMID 29958797, PMID 32031570, PMID 32171076, PMID 39393433, PMID 29515037, PMID 29674506, PMID 35075289, PMID 42031097, PMID 19549917, PMID 20004776, PMID 23053510, PMID 23317527, PMID 23818196, PMID 24139498, PMID 24290292, PMID 24331379, PMID 25075835, PMID 25736990, PMID 27262745, PMID 28159511, PMID 28637287, PMID 28809387, PMID 29419434, PMID 30193936, PMID 30346831, PMID 30476587, PMID 30900158, PMID 30964365, PMID 31262379, PMID 31626990, PMID 31657082, PMID 31798645, PMID 33789616, PMID 34182150, PMID 34389506, PMID 34724566, PMID 36574003, PMID 36818468, PMID 37718471, PMID 38446574, PMID 39735351, PMID 41711386, PMID 41749054, PMID 42606118, PMID 42777242, PMID 10049409, PMID 10091805, PMID 10092690, PMID 10561360

NIH funding

2014 (9), 2018 (7), 2016 (6), 2023 (6), 2015 (5), 2019 (4), U54AI117804 (4), 2009 (3), P30CA016672 (3), UL1TR001082 (3), 2017 (2), 2025 (2), U10CA095861 (2), 2005 (1), K23DK090073 (1)